“The FDA’s failure to require that Philip Morris present evidence about the impact of its marketing on America’s youth repeats an egregious error the FDA has made in the past, one that undermines a core goal of the Tobacco Control Act.”
…the company failed to demonstrate that the marketing of IQOS with modified risk claims will not increase initiation of tobacco use by non-users, particularly youth, or that the marketing for the product will target only adult smokers. The evidence also indicates that the marketing of IQOS with modified risk claims will lead to greater dual use with cigarettes instead of leading substantial numbers of smokers to switch completely to IQOS…
Continue to read the full article using the link below. This is important as our youth are easily addicted to flavoring, as we have learned from previous studies.
Like this:
Like Loading...
Related
